Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. 1983

P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000609 Aminoacridines Acridines which are substituted in any position by one or more amino groups or substituted amino groups.
D000677 Amsacrine An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent. m-AMSA,AMSA,AMSA P-D,Amsacrina,Amsidine,Amsidyl,Cain's Acridine,NSC-141549,NSC-156303,NSC-249992,SN-11841,SN11841,meta-AMSA,AMSA P D,AMSA PD,Cain Acridine,Cains Acridine,NSC 141549,NSC 156303,NSC 249992,NSC141549,NSC156303,NSC249992,SN 11841,meta AMSA

Related Publications

P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia
December 1987, Cancer treatment reports,
P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia
July 1996, Gynecologic oncology,
P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia
October 2000, Gynecologic oncology,
P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia
February 1991, Investigational new drugs,
P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia
December 1984, Cancer treatment reports,
P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia
July 2009, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia
August 1983, American journal of clinical oncology,
P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia
August 1983, American journal of clinical oncology,
P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia
August 1981, Cancer,
P Bonomi, and J A Blessing, and T V Sedlacek, and H D Homesley, and P J DiSaia
December 1993, American journal of clinical oncology,
Copied contents to your clipboard!